Presentation: Clinical Update on Endometriosis & Uterine Fibroids

Hugh S. Taylor, MD
Chair of Obstetrics, Gynecology, and Reproductive Sciences
Yale School of Medicine
Chief, Obstetrics and Gynecology
Yale-New Haven Hospital
New Haven, CT


Learning Objectives

After viewing this presentation, the participant should be able to:
  • Assess limitations of current treatment options for women with endometriosis
  • Examine the novel role of stem cells in the pathogenesis of endometriosis
  • Discuss utility of circulating miRNAs as biomarkers for disease
  • Evaluate the significant unmet clinical need for uterine fibroid management
  • Review emerging agents being evaluated for as long-term treatment for endometriosis and fibroids


 top 
 

Target Audience

This activity is intended for the education of nurses and nurse practitioners specializing in reproductive medicine and assisted reproductive technologies.

 top 


Requirements for Successful Completion

To successfully complete this activity for CE credit, the participant will:
1. Take the pretest
2. Review the content in the presentation
3. Complete the posttest with a score of at least 3 correct answers
4. Fill out a brief evaluation


Upon completion of the requirements 1 – 4, a CE certificate will be available for download.


Release & Expiration Dates
February 2021 to August 2021


 top 


Disclosure Information and Off-Label Uses
It is the policy of Letters & Sciences to ensure balance, independence, objectivity, and scientific rigor in all their sponsored educational activities. All faculty members participating in this activity are expected to disclose to the learners any real or perceived conflicts of interest related to the content of their presentations.

It is not assumed that any financial interests or affiliations will have an adverse impact on the faculty presentations. They simply are noted here to fully inform participants.


Jason A. Barritt, PhD, ELD, HCLD
  • Has no relationships to disclose
  • Will not be discussing or referring to unlabeled/unapproved uses of drugs, devices, products, protocols, or therapeutic strategies

Lauren J. Isley, MS, LCGC
  • Is a full time employee of Generate Life Sciences, a company providing donor gamete services
  • Has agreed to disclose any unlabeled/unapproved uses of drugs or products referenced in her presentation

Carol B. Lesser, MSN, NP-C
  • Has no relationships to disclose
  • Will not be discussing or referring to unlabeled/unapproved uses of drugs, devices, products, protocols, or therapeutic strategies

Kaylen M. Silverberg, MD
  • Has served as a consultant to AbbVie, Baxter, and EMD Serono
  • Will be discussing or referring to unlabeled/unapproved uses of oral progesterone

Hugh S. Taylor, MD
  • Has received grant/research support from Abbvie
  • Has Founders Options: DOTLab
  • Has agreed to disclose any unlabeled/unapproved uses of drugs or products referenced in his presentation

Executive Committee, CNE Committee, Planning Committee, Curriculum Committee Members
Letters & Sciences, the content managers/ members of the planning, executive and curriculum committees, report no relationships with commercial interests.

External Review
In accordance with the policies of Letters & Sciences, and in compliance with the standards of ANCC and ACCME to identify and resolve any potential conflicts of interest, to assure fair balance, independence and objectivity, and to instill scientific rigor in all accredited activities, all presentations with any potential for conflicts of interest, have been reviewed by external reviewers. The external reviewers, who have no potential conflicts of interest, have determined that no bias exists in these presentations. The external reviewers are:

Shannon L. DeVita, MSN, RN, CNL, DNP
Nurse Practionier
San Diego, California

Michele Nichols, PharmD
Pharmacy Consultant
Private Practice
Raritan, New Jersey
 top 

Accreditation Statements

Continuing Nursing Education with Distinction & Credit Designation
Letters & Sciences is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Each activity has been designated for 0.5 contact hours.

Nonendorsement of Products
The learner is advised that the educational content contained herein was developed by and reflects the opinions of the presenters and faculty, and does not necessarily reflect the opinions or recommendations of the educational provider or the commercial supporters. Accredited status does not imply endorsement by Letters & Sciences or the American Nurses Credentialing Center’s Commission on Accreditation of any commercial product discussed/displayed in conjunction with the educational activities.

 top 


Commercial Support

This activity is supported by educational grants from EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, and Ferring Pharmaceuticals, Inc.


 top 

 

Each CNE activity on this website is eligible for individual credit.